Rheumatology credentialing involves specific considerations around biologic drug administration and infusion therapy. Many rheumatology practices offer in-office infusion services for medications like infliximab, rituximab, and tocilizumab, which requires credentialing for both the physician services and the drug administration facility. ABIM rheumatology board certification is the standard requirement. Rheumatology is a shortage specialty in many markets, which can both ease credentialing (payers need network adequacy) and complicate it (limited panel positions).
Board Certification
Typical Credentialing Timeline
Planning guidance only—not a guarantee. Requirements, network capacity, contracting, and payer review can affect timing and effective dates.
Credentialing Challenges for Rheumatology
Frequently Asked Questions
Does biologic infusion require special credentialing?
Yes. Rheumatology practices offering in-office infusion services need to credential for drug administration, demonstrate proper handling and storage protocols, and may need facility-level certification for infusion suites.
Are rheumatology panels often open for new providers?
Rheumatology is a shortage specialty in many areas, so payer panels are often open. However, some saturated urban markets may have limited openings. Network adequacy requirements generally work in favor of rheumatologists seeking enrollment.
How does the prior authorization burden affect rheumatology?
Rheumatology has among the highest prior authorization requirements due to expensive biologic medications. While this is a post-credentialing operational issue, some payers require demonstrated prior auth compliance capability during credentialing.
Reviewed by Arctic Health Team , Credentialing Specialists
Last reviewed: September 2026
Information on this page reflects our experience as of September 2026. Credentialing requirements, payer processes, and state regulations may change. Contact us or check the relevant state medical board and payer websites for the most current requirements. This content is for informational purposes only and does not constitute legal or professional advice.